Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs MyStart Health

Invigor Medical
Graded #15

Higher grade

vs+19
MyStart Health
Graded #168

Lower grade

The verdict

Invigor Medical takes it — 86.1/100 to 67.1/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvigor Medical +36
84
48
Dose & formulationInvigor Medical +1
84
83
Clinical oversightInvigor Medical +4
88
84
Labs & monitoringInvigor Medical +20
86
66
FulfillmentInvigor Medical +10
88
78
Contract termsInvigor Medical +59
90
31
Invigor Medical · left barMyStart Health · right bar

The numbers

MetricInvigor MedicalMyStart Health
WeighScore86.1/10067.1/100
GradeBC
Scorecard rank#15#168
Semaglutide$199/mo$299/mo (all doses, compounded)
Tirzepatide$339/mo$299/mo (all doses, compounded)
CoverageNot disclosedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Invigor Medical

Graded #15 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

Where it loses points

  • No explicit states list
  • Compounded only
MyStart Health

Graded #168 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard